Lineage Cell Therapeutics updates COR1 corneal cell therapy program
Go back to Lineage Cell Therapeutics updates COR1 corneal cell therapy program| (NYSE: LCTX) | Delayed: 1.03 -0.04 (3.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.07 | 52 Week High | $ | |||
| Open | $1.10 | 52 Week Low | $ | |||
| Day High | $1.10 | P/E | N/A | |||
| Day Low | $1.03 | EPS | $ | |||
| Volume | 901,701 | |||||

